Satisfaction with the Use of Different Technologies for Insulin Delivery and Glucose Monitoring Among Adults with Long-Standing Type 1 Diabetes and Problematic Hypoglycemia: 2-Year Follow-Up in the HypoCOMPaSS Randomized Clinical Trial.
Jane Speight, Elizabeth Holmes-Truscott, Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, Horn Kai Tan, Anita Bowes, David Kerr, Daniel Flanagan, Simon R Heller, Mark L Evans, James AM Shaw
Diabetes Technology & Therapeutics | Mary Ann Liebert Inc | Published : 2019
Background: In the HypoCOMPaSS trial, adults with long-standing type 1 diabetes and problematic hypoglycemia were randomized to compare insulin pump (continuous subcutaneous insulin infusion; CSII) with multiple daily injections (MDI) and real-time continuous glucose monitoring (RT-CGM) with conventional self-monitoring of blood glucose (SMBG). Our aim was to investigate participants' satisfaction with these technologies at 6-month randomized, controlled trial (RCT) endpoint and at 2-year follow-up. Methods: Participants completed the Insulin Treatment Satisfaction Questionnaire subscales "device delivery" and "hypoglycemia c..View full abstract